Organism name | Neolitsea acuminatissima |
---|---|
Genus | Neolitsea |
Family | Lauraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Neolitsea |
---|---|
Linked NCBI taxonomy ID | 128654 |
Linked level | genus |
Family in NCBI taxonomy | Lauraceae |
---|---|
ID | 3433 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Magnoliophyta |
---|---|
ID | 3398 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00027304
![]() |
Boldine
/ d-Boldine / (+)-Boldine |
CHEMBL388342
CHEMBL1321247 CHEMBL1437753 |
C011686
|
34 / 32 / 35 | No. 20 | No. 4 |
![]() |
|
C00001790
![]() |
Actinodaphnine
/ (+)-Actinodaphnine / 1,2-Methylenedioxy-9-hydroxy-10-methoxynoraporphine |
CHEMBL518088
CHEMBL1588263 |
C060992
|
30 / 32 / 24 | No. 20 | No. 4 |
![]() |
|
C00001807
![]() |
Anonaine
/ (-)-Anonaine / (R)-Annonaine |
CHEMBL401798
|
C098138
|
1 / 0 / 0 | No. 20 | No. 4 |
![]() |
|
C00001834
![]() |
Cassythicine
/ (+)-Cassythicine / N-Methylactinodaphnine / (+)-N-Methylactinodaphnine |
CHEMBL464528
|
No. 20 | No. 4 |
![]() |
|||
C00044392
![]() |
(-)-Boldine
|
CHEMBL388342
CHEMBL1321247 CHEMBL1437753 |
34 / 32 / 35 | No. 20 | No. 4 |
![]() |
||
C00027433
![]() |
Laurolitsine
/ (+)-Norboldine / (+)-Laurolitsine |
CHEMBL487388
|
C109133
|
No. 20 | No. 4 |
![]() |
||
C00002631
![]() |
(+)-Lirioresinol B
/ (+)-Syringaresinol |
CHEMBL361362
CHEMBL402653 |
C042192
|
1 / 0 / 0 | No. 38 | No. 21 |
![]() |
|
C00003672
![]() |
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
![]() |
||
C00023774
![]() |
Fucostanol
/ Stigmasterol / Dihydro-beta-sitosterol / (24S)24-Ethylcholestain-3beta-ol |
CHEMBL66943
CHEMBL186373 CHEMBL400247 CHEMBL1568947 |
D013265
|
5 / 0 / 0 | 1 / 0 | No. 53 | No. 11 |
![]() |
C00001878
![]() |
Liriodenine
/ Oxoushinsunine / Spermatheridine |
CHEMBL37736
|
C026980
|
5 / 3 / 1 | No. 74 |
![]() |
||
C00027457
![]() |
Oxoglaucine
/ O-Methylatheroline |
CHEMBL470881
|
C111587
|
25 / 27 / 24 | No. 74 |
![]() |
||
C00044955
![]() |
Neolitacumone B
/ (+)-Neolitacumone B |
No. 178 | No. 38 |
![]() |
||||
C00001910
![]() |
Reticuline
/ (+)-Reticuline |
CHEMBL235212
CHEMBL401501 CHEMBL464734 |
C003298
|
1 / 0 / 0 | No. 345 | No. 4 |
![]() |
|
C00025988
![]() |
Sebiferine
/ (9R)-Sebiferine / O-Methylflavinantine / (+)-O-Methylflavinanthine / (+)-O-Methylflavinantine |
CHEMBL224744
CHEMBL490139 |
C024736
|
No. 426 | No. 4 |
![]() |
||
C00031628
![]() |
beta-Sitosteryl-D-glucoside
|
CHEMBL197711
CHEMBL506678 CHEMBL2304043 |
5 / 4 / 2 | No. 520 |
![]() |
|||
C00044826
![]() |
Isovanillin
|
CHEMBL275563
|
C093382
|
7 / 8 / 4 | No. 1003 |
![]() |
||
C00044954
![]() |
Neolitacumone A
|
No. 1017 |
![]() |
|||||
C00027422
![]() |
Neolitacumonine
|
No. 1137 |
![]() |
|||||
C00044956
![]() |
Neolitacumone C
/ (+)-Neolitacumone C |
No. 1624 |
![]() |
|||||
C00030771
![]() |
Methylparaben
/ p-Methoxycarbonylphenol |
CHEMBL325372
|
C015358
|
102 / 49 / 57 | 3 / 0 | No. 2169 |
![]() |
|
C00000258
![]() |
2,6-Dimethoxy-p-benzoquinone
|
CHEMBL448515
|
C030511
|
22 / 32 / 55 | No. 2517 |
![]() |
||
C00029536
![]() |
p-Anisic acid
/ 4-Methoxybenzoic acid |
CHEMBL21932
|
C004520
|
3 / 2 / 3 | No. 2930 |
![]() |
||
C00007205
![]() |
(+)-Lyoniresinol
|
CHEMBL455365
CHEMBL1760594 CHEMBL1761710 |
No. 4145 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q9UNA4 | DNA polymerase iota | Enzyme | C00000258 C00001790 C00027304 C00030771 C00044392 C00044826 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000258 C00003672 C00027304 C00027457 C00030771 C00044392 | 0 / 1 |
O75496 | Geminin | Unclassified protein | C00000258 C00001790 C00027304 C00027457 C00044392 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000258 C00001790 C00027304 C00027457 C00044392 | 4 / 3 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003672 C00027304 C00027457 C00030771 C00044392 | 1 / 1 |
P39748 | Flap endonuclease 1 | Enzyme | C00000258 C00001790 C00027304 C00027457 C00044392 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00001790 C00003672 C00023774 C00027457 C00031628 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003672 C00027304 C00027457 C00030771 C00044392 | 0 / 1 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000258 C00001790 C00027304 C00027457 C00044392 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000258 C00001790 C00027304 C00027457 C00044392 | 1 / 2 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003672 C00027304 C00027457 C00030771 C00044392 | 1 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003672 C00027304 C00030771 C00044392 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001790 C00027304 C00027457 C00044392 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001790 C00027304 C00027457 C00044392 | 1 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00000258 C00001790 C00027304 C00044392 | 1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001790 C00027304 C00027457 C00044392 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001790 C00027304 C00027457 C00044392 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00001790 C00027304 C00027457 C00044392 | 11 / 10 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000258 C00001790 C00027304 C00044392 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001790 C00027304 C00027457 C00044392 | 1 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001790 C00027304 C00027457 C00044392 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001790 C00027304 C00027457 C00044392 | 2 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001790 C00027304 C00044392 C00044826 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001790 C00027304 C00044392 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000258 C00001790 C00027457 | 2 / 0 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00001878 C00027304 C00044392 | 1 / 1 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00001878 C00027304 C00044392 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001790 C00027304 C00044392 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000258 C00027457 C00044826 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000258 C00027457 C00030771 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00000258 C00027304 C00044392 | 2 / 5 |
P03372 | Estrogen receptor | NR3A1 | C00003672 C00030771 | 1 / 1 |
Q14761 | Protein tyrosine phosphatase receptor type C-associated protein | Enzyme | C00001807 C00001878 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003672 C00027457 | 1 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00027304 C00044392 | 3 / 3 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00000258 C00001790 | 1 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00029536 C00030771 | 1 / 2 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00027304 C00044392 | 0 / 0 |
P00734 | Prothrombin | S1A | C00003672 C00031628 | 4 / 2 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00027304 C00044392 | 1 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001910 C00030771 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00027304 C00044392 | 0 / 1 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00000258 C00044826 | 7 / 3 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00027304 C00044392 | 1 / 4 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000258 C00001790 | 4 / 1 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 C00031628 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 C00031628 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000258 C00030771 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00030771 C00044826 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00029536 C00030771 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000258 C00030771 | 7 / 37 |
P29466 | Caspase-1 | C14 | C00027457 C00030771 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00001790 C00027457 | 1 / 1 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00027304 C00044392 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 C00031628 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00027304 C00044392 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00030771 C00044826 | 1 / 1 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00000258 C00001790 | 2 / 1 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00030771 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00030771 | 1 / 1 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00030771 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00030771 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00030771 | 1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00030771 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00030771 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001790 | 2 / 2 |
O43570 | Carbonic anhydrase 12 | Lyase | C00030771 | 1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00030771 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00030771 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00030771 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00030771 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00030771 | 2 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000258 | 2 / 3 |
P11387 | DNA topoisomerase 1 | Isomerase | C00002631 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00030771 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00030771 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00030771 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00030771 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00030771 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00030771 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00030771 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00030771 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00030771 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00030771 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00030771 | 1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00030771 | 1 / 8 |
P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00001878 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00030771 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00030771 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00030771 | 1 / 0 |
P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00001878 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00030771 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00030771 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00030771 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00030771 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001790 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00030771 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00003672 | 1 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00001790 | 0 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00023774 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00030771 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00030771 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00030771 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00003672 | 4 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00030771 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00030771 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00030771 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00030771 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00030771 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00030771 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00030771 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00030771 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00030771 | 1 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00030771 | 2 / 1 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00030771 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00030771 | 0 / 1 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00030771 | 1 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00030771 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00030771 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00030771 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00030771 | 1 / 1 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 1 |
P09884 | DNA polymerase alpha catalytic subunit | Transferase | C00023774 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00030771 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00030771 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00030771 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00030771 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00030771 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00030771 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00030771 | 0 / 0 |
P51580 | Thiopurine S-methyltransferase | Enzyme | C00029536 | 1 / 1 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00000258 | 0 / 0 |
Q92793 | CREB-binding protein | Enzyme | C00027457 | 1 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00030771 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00030771 | 2 / 2 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001790 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00030771 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00030771 | 5 / 1 |
P17252 | Protein kinase C alpha type | Alpha | C00030771 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00030771 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00030771 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00030771 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00030771 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00030771 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00030771 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00030771 | 0 / 0 |
Q06278 | Aldehyde oxidase | Enzyme | C00044826 | 0 / 1 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00030771 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00030771 | 0 / 0 |
Q2TB90 | Putative hexokinase HKDC1 | Enzyme | C00000258 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00030771 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00030771 | 2 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00030771 | 2 / 2 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00030771 | 0 / 3 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00030771 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00023774 | 0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00023774 | 0 / 0 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00001790 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00030771 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00030771
|
3952 | LEP, LEPD, OB, OBS | leptin |
C00030771
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00030771
|
10599 | SLCO1B1, HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6 | solute carrier organic anion transporter family, member 1B1 |
C00023774
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
Q14191 |
#218800 | Crigler-najjar syndrome, type i |
P22309
|
#606785 | Crigler-najjar syndrome, type ii |
P22309
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#180849 | Rubinstein-taybi syndrome 1; rsts1 |
Q92793
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#612052 | Smoking as a quantitative trait locus 3; sqtl3 |
P32297
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P00734
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#610460 | Thiopurine s-methyltransferase deficiency |
P51580
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) |
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00192 | Xanthinuria |
P47989
(related)
Q06278 (related) |
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) |
P51580
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00296 | Defects in RecQ helicases |
Q14191
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00504 | Rubinstein-Taybi syndrome |
Q92793
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|